
Lytix Biopharma AS
LYTIX | OL
Overview
Corporate Details
- ISIN(s):
- NO0010405780
- LEI:
- 549300NXMIMRSBCDZO71
- Country:
- Norway
- Address:
- Sandakerveien 138, 0484 OSLO
- Website:
- https://www.lytixbiopharma.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Lytix Biopharma is a Phase II clinical stage drug development company with more than 20 years of preclinical and clinical research. Since June 2021 the company is listed on Euronext Growth. Lytix has, in collaboration with world leading cancer research centers, developed a proprietary in situ vaccination technology platform providing a new class of drug candidates for the treatment of cancer. The treatment is aiming for activating the patient’s own immune system to fight the cancer. In total this program covers a range of cancer indications, and it works both as monotherapy and in combination with immune checkpoint inhibitors (ICIs) and as adjunct to cell therapy. The ambition of the development program is to ensure that the entire potential of the technology platform will be revealed and released. To achieve this, Lytix has entered – and is prepared to enter further – into scientific, clinical and commercial collaborations worldwide.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-05-21 14:05 |
Directors' Dealings
Lytix Biopharma AS: GRANT OF SHARE OPTIONS
|
English | 223.9 KB | |
2025-05-21 14:05 |
Remuneration Report
Lytix Biopharma AS: GRANT OF SHARE OPTIONS
|
English | 2.2 KB | |
2025-05-15 05:00 |
Investor Presentation
Lytix Biopharma Q1 2025: Strong clinical momentum supports a clear path to Phas…
|
English | 2.8 MB | |
2025-05-15 05:00 |
Earnings Release
Lytix Biopharma Q1 2025: Strong clinical momentum supports a clear path to Phas…
|
English | 5.4 KB | |
2025-05-09 05:00 |
Report Publication Announcement
Lytix Biopharma: Invitation to Q1 2025 Results Presentation
|
English | 129.9 KB | |
2025-05-09 05:00 |
Report Publication Announcement
Lytix Biopharma: Invitation to Q1 2025 Results Presentation
|
English | 2.0 KB | |
2025-04-29 12:19 |
Declaration of Voting Results & Voting Rights Announcements
Lytix Biopharma AS: Minutes from Ordinary General Meeting and Election of New B…
|
Norwegian | 172.5 KB | |
2025-04-29 12:19 |
Declaration of Voting Results & Voting Rights Announcements
Lytix Biopharma AS: Minutes from Ordinary General Meeting and Election of New B…
|
English | 4.3 KB | |
2025-04-22 19:18 |
Board/Management Change
Lytix Biopharma AS: Recommendation from the Nomination and Compensation Committ…
|
English | 164.6 KB | |
2025-04-22 19:18 |
Proxy Solicitation & Information Statements
Lytix Biopharma AS: Recommendation from the Nomination and Compensation Committ…
|
English | 117.5 KB | |
2025-04-22 19:18 |
Board/Management Change
Lytix Biopharma AS: Recommendation from the Nomination and Compensation Committ…
|
English | 2.3 KB | |
2025-04-10 05:10 |
General Meeting Notice
Lytix Biopharma AS: Notice of Annual General Meeting on 29 April 2025
|
Norwegian | 227.7 KB | |
2025-04-10 05:10 |
General Meeting Notice
Lytix Biopharma AS: Notice of Annual General Meeting on 29 April 2025
|
English | 37.0 KB | |
2025-04-10 05:10 |
General Meeting Notice
Lytix Biopharma AS: Notice of Annual General Meeting on 29 April 2025
|
English | 1.3 KB | |
2025-04-10 05:00 |
Annual Report
Lytix Biopharma AS: Annual Report for 2024
|
English | 1.7 MB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
1NKEMIA | Spain | IKM | |
![]() |
2cureX AB | Sweden | 2CUREX | |
![]() |
4SC AG | Germany | VSC | |
![]() |
Abera Bioscience AB | Sweden | ABERA | |
![]() |
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
![]() |
AB Science | France | AB | |
![]() |
Acticor Biotech | France | ALACT | |
![]() |
Active Biotech | Sweden | ACTI | |
![]() |
AcuCort AB | Sweden | ACUC |